RecallDepth
Class II Ongoing

Valsartan Tablets USP 80 mg, 90 count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ --- NDC 65862-571-90

This recall is currently active, issued March 27, 2019. It was issued by Aurobindo Pharma Usa Inc..

Company
Aurobindo Pharma Usa Inc.
Recall Initiated
December 31, 2018
Posted
March 27, 2019
Recall Number
D-1038-2019
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
East Windsor, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

Distribution

Product was distributed to major distribution chains throughout the United States.

Lot / Code Info

Lot Numbers: 471170015A, exp. date Sep 2019; 471180004A, 471180005A, exp. date Feb 2019

More recalls by Aurobindo Pharma Usa Inc.

View all recalls by this company →

Other recent Class II Drug recalls